FGF2 and medulloblastoma: In this context, the suppression of angiogenesis-mediated tumour growth by SPARC in medulloblastoma seems to be the consequence of its ability to inhibit the expression of angiogenic factors such as MMP-9, bFGF and VEGF in tumour tissues, which may in turn inhibit capillary infiltration into tumours.